A 10-Month Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder

摘要

Background:The primary objective was to evaluate the long-term safety of desvenlafaxine (administered as desvenlafaxine succinate) during open-label treatment in adult outpatients with a primary DSM-IV diagnosis of major depressive disorder (MDD).